These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 822547)

  • 1. A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report.
    Tubercle; 1976 Jun; 57(2):105-13. PubMed ID: 822547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.
    Tubercle; 1975 Mar; 56(1):1-26. PubMed ID: 1096388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.
    Tubercle; 1975 Sep; 56(3):179-89. PubMed ID: 766340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
    Tubercle; 1977 Mar; 58(1):1-8. PubMed ID: 325837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
    Kohno S; Koga H; Kaku M; Maesaki S; Hara K
    Chest; 1992 Dec; 102(6):1815-8. PubMed ID: 1446494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1971 Sep; 46(9):371-7. PubMed ID: 4330662
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
    Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis.
    Castelo A; Jardim JR; Goihman S; Kalckman AS; Dalboni MA; da Silva EA; Haynes RB
    Lancet; 1989 Nov; 2(8673):1173-6. PubMed ID: 2572899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong.
    Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions.
    Hong YP; Kim SC; Chang SC; Kim SJ; Jin BW; Park CD
    Tubercle; 1988 Dec; 69(4):241-53. PubMed ID: 3076999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.